Experimental treatment for Ovarian Cancer is underway at 15 medical centers across the country, and women like Corinne Lane are getting it in the nose. Early studies are already showing the Immunotherapy nose drop is helping patients with advanced stage Ovarian Cancer live longer.
The nose drops contain an experimental cancer fighter called I-M 862. It's a drug that boosts the immune system by blocking the development of blood vessels that tumors need to grow and spread. Dr. Shashikant Lele, m.d.and Oncologist on the research team, says "We hold great hope that by giving immunotherapy to chemotherapy we can improve on the survival of women cancer patients which is right now very dismal or poor."
I-M-862 is being tested in patients with Stage Three Disease who have had no other treatments besides surgery. The drug appears to be well tolerated with only mild side effects such as headache, nausea, vomiting, and abdominal pain.
Researchers are hoping that if this study is successful, the nose drops could be used to treat Prostate, Breast, and Colorectal Cancers as well. As yet, no medical center in Texas is included in the I-M-862 nose drop study.
The trial is being conducted in the following cities: Glendale, Ca.; Los Angeles, Ca; Los Gatos, Ca,; Hollywood, Florida,; Stanford, Ca,; Miami, Fl,; Atlanta, Ga,; Minneapolis, Mn,; St. Louis, Mo; Omaha, Nevada; Las Vegas, Nv; Buffalo, Ny; Chapel Hill, NC; Cleveland Ohio; Columbus Oh; Pittsburgh, Pa; Burlington, Vt, Seattle, Wa,; Madison, Wi; and Washington D.C.